Population Data-Driven Formulation of a COVID-19 Therapeutic.

HR Campbell, RP Cecil, R Lodder

Research output: Contribution to journalArticle


This study is designed to utilize computer modeling of the US population through NHANES to reduce the need for preclinical formulation and toxicology studies of an Ebola anti-viral (BSN389) being repurposed for COVID-19, and to thereby speed the candidate therapeutic to the clinic.
Original languageEnglish
JournalMedRxiv : the preprint server for health sciences
StatePublished - Jul 27 2020


Dive into the research topics of 'Population Data-Driven Formulation of a COVID-19 Therapeutic.'. Together they form a unique fingerprint.

Cite this